Long-Term Surveillance of Ocrelizumab Treated Patients With Multiple Sclerosis (MANUSCRIPT Study)

28/02/2019
14/03/2024
EU PAS number:
EUPAS28619
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol BA39730 ocrelizumab Final v1_approved_Redacted

English (1.86 MB - PDF) View document
Updated protocol

Prot BA39730 ocrelizumab v1, Published_Redacted

First published: 22/02/2024
English (1.87 MB - PDF) View document
Study results
Study report
Other information